| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | China | 3 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Australia | 1 | |
| #6 | Canada | 1 | |
| #7 | Japan | 1 | |
| #8 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Liu Hongli | 17 |
| #2 | Liu Hong Li | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN111417402A | Medicine and method for treating hepatitis B virus related liver disease under full dosage condition | |
| CN111225680A | Therapeutic agent for non-alcoholic fatty liver disease | |
| KR20190015392A | Compositions and methods for treating metabolic diseases | |
| US2017112898A1 | Formulations of hepalatide |